Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...
Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...
In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond ...
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...
Ozempic has taken the world of Hollywood by storm — and now, doctors are advising people to rein it in a little. Of course, ...